The Patent Finder

Enzo Biochem, Inc.

35 patents currently held · Updated Nov 16, 2026
11 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

9
Ending by 2030
Dec 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 3 fees due Dec 6 to 25, 2026 · next Dec 6
  • 1 fee due Feb 15, 2027
    The maintenance fee for Sphingosine Pathway Modulating Compounds for the Treatment of Coronavirus Infection (US 11,723,895) comes due Feb 15, 2027. Unpaid by Aug 16, 2027, it lapses early.
  • 2 fees due Mar 5 to 15, 2027 · next Mar 5
  • 1 fee due Jun 3, 2027
    The maintenance fee for Diagnosis and Treatment of Viral Diseases (US 10,495,641) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
  • 1 fee due Aug 2, 2027
    The maintenance fee for Autophagy and Phospholipidosis Pathway Assays (US 9,250,249) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
  • 1 fee due Sep 19, 2027
    The maintenance fee for Sphingosine Pathway Modulating Compounds For The Treatment Of Coronavirus Infection (US 11,931,344) comes due Sep 19, 2027. Unpaid by Mar 20, 2028, it lapses early.
  • 1 fee due Oct 21, 2027
    The maintenance fee for Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor (US 10,626,170) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Sphingosine Pathway Modulating Compounds for the Treatment of Cancers (US 10,646,459) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 terms have ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 11,066,694Affinity Tag Nucleic Acid and Protein Compositions, and Processes for Using Same
In force
 · Medium confidence
In forceMedium confidence
US 10,196,672Affinity Tag Nucleic Acid and Protein Compositions, and Processes for Using Same
In force
 · Medium confidence
In forceMedium confidence
US 8,097,405Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,124,334Selective Detection of Oncogenic HPV
In force
 · High confidence
In forceHigh confidence
US 9,932,479Novel Dyes and Compositions, and Processes for Using Same in Analysis of Protein Aggregation and Other Applications
In force
 · High confidence
In forceHigh confidence
US 9,403,882Sulfation of WNT Pathway Proteins
In force
 · High confidence
In forceHigh confidence
US 10,626,170Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor
In force
 · High confidence
In forceHigh confidence
US 10,899,827Antibodies Specific for Sulfation Sites of Sclerostin
In force
 · High confidence
In forceHigh confidence
US 11,667,703Sulfonated Sclerostin, Antibodies, Epitopes and Methods for Identification and Use Therefor
In force
 · High confidence
In forceHigh confidence
US 10,328,120Pharmaceutical Compositions Targeting WNT Pathway Proteins
In force
 · High confidence
In forceHigh confidence
10 of 35 patents shown.
Pro members see all 35.
Pro members: see all 35 patents
Also on record, not counted in the 35: 11 patents in force now held by others · 2 lapsed for an unpaid fee · 60 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 28 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited